Teva to sell Quebec plant, transfer 150 jobs; FTC studies PBM merger for impact on specialty pharma;

@FiercePharma: Who could make a play for Amylin next? AstraZeneca and Sanofi, per analysts. Bristol-Myers may return, too. Article | Follow @FiercePharma

> Teva Pharmaceutical Industries ($TEVA) is selling a Quebec plant to contract manufacturer Halo Pharmaceuticals; 150 jobs will transfer as well. Item

> The Federal Trade Commission is studying how the merger of Express Scripts ($ESRX) and Medco Health Solutions ($MHS) would affect availability and pricing of specialty drugs. Article

> Big Pharma spends €40 million a year lobbying decision-makers in the EU. Report

> Horizon Pharma sued Par Pharmaceuticals ($PRX) for patent infringement after the latter asked the FDA to approve a copycat version of the arthritis pill Duexis. Story

> Standard & Poor's assigned an A- rating to Teva Pharmaceutical Industries' proposed senior unsecured notes. Item

> India's Aurobindo Pharma joins the crowd of generics makers with an approved version of AstraZeneca's ($AZN) newly off-patent antipsychotic Seroquel. News

Biotech News

@FierceBiotech: Who thinks they've got the tonic for Big Pharma social media headaches? This guy does: Piece | Follow @FierceBiotech

@JohnCFierce: VC boom: U.K. charity births $80M biotech fund for cancer drug research--I count $730M in new U.K./euro funds this month. Story | Follow @JohnCFierce

@RyanMFierce: Moscow backs clones of Western biotech programs in Russia. More | Follow @RyanMFierce

@FierceMedDev: Roche raises bid for U.S. diagnostics firm Illumina - San Jose Mercury News. Article | Follow @FierceMedDev

> Optimer inks $90M C. difficile drug pact with Astellas. News

> Cetero preps for new owner after filing for bankruptcy protection. Item

> Is an Amylin takeover inevitable after the BMS rejection? More

Manufacturing News

> CMC, third-party manufacturing issues delay Map drug launch. News

> California implant makers get FDA warnings. Article

> Novartis plant disruptions affect pet treatments. Story

> Sandoz Canada president explains shortages to House of Commons. Article

> Halo agrees to buy Teva's Montreal facility. Report

CRO News

> Parexel should see more revenue, higher share prices, analysts say. More

> Cetero sees strong future despite bankruptcy protection filing. Article

> INC Research axes staffers, closes Connecticut lab. Story

> Spaulding's hand-held ECG fuels tax credits and hiring boom. Item

> Report sheds light on pharma and CRO trial enrollment woes. News

Vaccines News

> Vaxfectin-based malaria vaccine could stop transmission. Item

> Narcolepsy spike linked with flu shot. Story

> Academics' oral stomach flu vax could save lives. Article

> Genetic tweaking could create Chlamydia vaccine. More

And Finally... Adding electricity to acupuncture may serve as an add-on treatment for depression, researchers found. Report

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.